Patrick de Boer
Chief Executive Officer
Who we are
The people behind the read-outs
Aiosyn is a spin-off from the computational pathology group at Radboud University Medical Center, built on more than twenty years of research into reading tissue at scale. We pair that pathology depth with modern machine learning to give preclinical studies objective, reproducible quantification.
Management
Jeroen van der Laak
Chief Scientific Officer
Wouter Bulten
Chief Operating & Product Officer
David Tellez
Chief Technology Officer
Team
Peter Bandi
Senior Software Engineer
Thomas de Bel
AI Scientist
Xabier Arregui
AI Engineer
Our focus-area models are developed through a strategic collaboration with TNO, and guided by a scientific advisory board of pathologists and researchers in the field.
Want to work with us on your study?
Whether it is one of our focus areas or a custom analysis, we would like to hear what you are trying to measure.